Alzheimer’s Disease

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
The therapeutic potential of the endocannabinoid system for Alzheimer’s disease
Endocannabinoid signalling in Alzheimer’s disease
A molecular link between the active component of marijuana and Alzheimer’s disease pathology
Neuroprotective effect of CBD… on beta-amyloid-induced toxicity in PC12 cells
The Potential Therapeutic Effects of THC on Alzheimer’s Disease
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
Cannabinoids for the treatment of dementia
CBD in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
CBD: A promising drug for neurodegenerative disorders?
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
The role of the endocannabinoid system in Alzheimer’s disease
The role of phytochemicals in the treatment and prevention of dementia
Cannabinoids for the treatment of dementia
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression inSHSY5YAPP+ Cells Through PPARγ Involvement
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
Can Marijuana Prevent Alzheimer’s?
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
CBD Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells
In vivo Evidence for Therapeutic Properties of CBD for Alzheimer’s Disease
Neurological aspects of medical use of CBD

What are your Feelings

Still stuck? How can we help?